AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
SciSparc Ltd. Ordinary Shares
XNAS · usd
SIC 2836 · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
FIGI BBG001SPR7B4
1.09▼ 0.11 (-9.17%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
—
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close
1.20
Day's Range
1.07 – 1.21
52-Week Range
0.46 – 15.79
Volume
205.1K
Avg Volume
1.2M
Share Statistics
Shares Outstanding
Employees
2
Exchange
XNAS
Listed
2021-08-27
Share count as of December 31, 2025

SciSparc Ltd. Ordinary Shares (SPRC) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about SciSparc Ltd. Ordinary Shares (SPRC)
What is SciSparc Ltd. Ordinary Shares's Market Cap?
SciSparc Ltd. Ordinary Shares's Market Cap is $398.3K, based on as-reported figures from SEC (XBRL) filings.
What is SciSparc Ltd. Ordinary Shares's Enterprise Value?
SciSparc Ltd. Ordinary Shares's Enterprise Value is -$3.8M, based on as-reported figures from SEC (XBRL) filings.
What is SciSparc Ltd. Ordinary Shares's Price / Sales?
SciSparc Ltd. Ordinary Shares's Price / Sales is 0.5×, based on as-reported figures from SEC (XBRL) filings.
What is SciSparc Ltd. Ordinary Shares's EV / Revenue?
SciSparc Ltd. Ordinary Shares's EV / Revenue is n/m, based on as-reported figures from SEC (XBRL) filings.
What is SciSparc Ltd. Ordinary Shares's EV / EBITDA?
SciSparc Ltd. Ordinary Shares's EV / EBITDA is 0.5×, based on as-reported figures from SEC (XBRL) filings.
What is SciSparc Ltd. Ordinary Shares's Revenue (TTM)?
SciSparc Ltd. Ordinary Shares's Revenue (TTM) is $856.0K, based on as-reported figures from SEC (XBRL) filings.
What is SciSparc Ltd. Ordinary Shares's Net Income (TTM)?
SciSparc Ltd. Ordinary Shares's Net Income (TTM) is -$12.6M, based on as-reported figures from SEC (XBRL) filings.
What is SciSparc Ltd. Ordinary Shares's EBITDA?
SciSparc Ltd. Ordinary Shares's EBITDA is -$8.3M, based on as-reported figures from SEC (XBRL) filings.
What is SciSparc Ltd. Ordinary Shares's Diluted EPS (TTM)?
SciSparc Ltd. Ordinary Shares's Diluted EPS (TTM) is -34.38, based on as-reported figures from SEC (XBRL) filings.
What is SciSparc Ltd. Ordinary Shares's EBITDA Margin?
SciSparc Ltd. Ordinary Shares's EBITDA Margin is -973.5%, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · SPRCAs-filed SEC (XBRL) data
No Quarterly data available for this company — showing Annual instead. This company files annual reports only — foreign private issuers (Form 20-F / 40-F) are not required to file quarterly reports, so no quarterly figures exist to show.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019Dec 31, 2018
Profit or loss [abstract]
Revenues
Cost of revenues
Gross profit
Research and development expenses
Sales, marketing and distribution
General and administrative expenses
Other income
Operating loss
Equity losses of an associate
Finance income
Finance expenses
Loss before income taxes
Net loss and total comprehensive loss
Equity holders of the Company
Non-controlling interests
Basic loss per ordinary share attributable to equity holders of the Company (in Dollars per share)
Diluted loss per ordinary share attributable to equity holders of the Company (in Dollars per share) (in Dollars per share)